Position in MRK
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$6,542,706
+$1,104,756 QoQ
Shares Held
50,916
+12.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#924
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Procyon Advisors, LLC holds $38,982,476 across 11 Drug Manufacturers - General names. MRK ranks #4 (16.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
32,392 | $8,151,122 | |
| 2 | JNJ |
Johnson & Johnson
|
30,495 | $7,744,815 | |
| 3 | LLY |
ELI LILLY & Co
|
6,408 | $7,685,948 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
50,916 | $6,542,706 | |
| 5 | AMGN |
Amgen Inc
|
6,850 | $2,480,522 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
17,103 | $2,160,793 | |
| 7 | PFE |
Pfizer Inc
|
55,347 | $1,332,755 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,718 | $963,291 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,542,706 | 50,916 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $5,437,950 | 45,207 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,566,524 | 33,883 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $2,452,182 | 29,217 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,783,949 | 22,536 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $4,097,633 | 45,651 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $3,946,371 | 39,670 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $4,799,840 | 42,267 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $5,138,566 | 41,507 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $5,252,269 | 39,805 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $3,915,017 | 35,911 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $3,748,306 | 36,409 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $2,442,806 | 21,170 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $1,342,216 | 12,616 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $1,744,577 | 15,724 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,168,045 | 13,563 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,329,076 | 14,578 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,436,859 | 17,512 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $1,255,056 | 16,376 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,306,914 | 17,400 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,790,343 | 23,021 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $955,916 | 12,400 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $872,969 | 10,672 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $841,113 | 10,140 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $787,683 | 10,186 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $693,152 | 9,009 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||